Omnicell Stock Price, News & Analysis (NASDAQ:OMCL)

Omnicell trades on the NASDAQ under the ticker symbol "OMCL."

Omnicell, Inc. (NASDAQ:OMCL) issued its quarterly earnings results on Thursday, July, 25th. The company reported $0.51 EPS for the quarter, beating analysts' consensus estimates of $0.47 by $0.04. The firm had revenue of $217.40 million for the quarter, compared to analysts' expectations of $214.13 million. Omnicell had a return on equity of 11.85% and a net margin of 5.70%. The business's revenue for the quarter was up 15.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.46 EPS. View Omnicell's Earnings History.

Omnicell is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Omnicell.

Omnicell will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Omnicell updated its FY19 earnings guidance on Thursday, July, 25th. The company provided earnings per share (EPS) guidance of $2.65-$2.82 for the period, compared to the Thomson Reuters consensus estimate of $2.77. The company issued revenue guidance of $886-$900 million, compared to the consensus revenue estimate of $891.96 million.

7 Wall Street analysts have issued 1 year target prices for Omnicell's shares. Their predictions range from $61.00 to $90.00. On average, they anticipate Omnicell's stock price to reach $80.29 in the next twelve months. This suggests a possible upside of 5.5% from the stock's current price. View Analyst Price Targets for Omnicell.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Omnicell in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Omnicell.

Press coverage about OMCL stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Omnicell earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Omnicell.

Some companies that are related to Omnicell include Nice (NICE), CAPCOM CO LTD/ADR (CCOEY), Teradata (TDC), Cray (CRAY), Fitbit (FIT), Super Micro Computer (SMCI), Huami (HMI), One Stop Systems (OSS), CCUR (CCUR) and Socket Mobile (SCKT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Omnicell investors own include AT&T (T), Johnson & Johnson (jnj), Gilead Sciences (GILD), Micron Technology (MU), Paypal (PYPL), AbbVie (ABBV), Adobe (ADBE), Align Technology (ALGN), Netflix (NFLX) and NVIDIA (NVDA).

Omnicell's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Stephens Investment Management Group LLC (0.80%), Tributary Capital Management LLC (0.65%), Peregrine Capital Management LLC (0.65%), Summit Creek Advisors LLC (0.53%), Scout Investments Inc. (0.44%) and Rhenman & Partners Asset Management AB (0.22%). Company insiders that own Omnicell stock include Dan S Johnston, Gary S Petersmeyer, James T Judson, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps, Robin Gene Seim and Scott Peter Seidelmann. View Institutional Ownership Trends for Omnicell.

OMCL stock was sold by a variety of institutional investors in the last quarter, including Pwmco LLC, Scout Investments Inc., Rhenman & Partners Asset Management AB, Tributary Capital Management LLC, Stephens Investment Management Group LLC, CIBC Private Wealth Group LLC and Envestnet Asset Management Inc.. Company insiders that have sold Omnicell company stock in the last year include Dan S Johnston, Gary S Petersmeyer, James T Judson, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps and Scott Peter Seidelmann. View Insider Buying and Selling for Omnicell.

OMCL stock was purchased by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Summit Creek Advisors LLC, Bowling Portfolio Management LLC, State of Alaska Department of Revenue, Assenagon Asset Management S.A., Zurcher Kantonalbank Zurich Cantonalbank , Stephens Inc. AR and West Coast Financial LLC. View Insider Buying and Selling for Omnicell.

Shares of OMCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OMCL stock can currently be purchased for approximately $76.07.

Omnicell has a market capitalization of $3.17 billion and generates $787.31 million in revenue each year. The company earns $37.73 million in net income (profit) each year or $1.53 on an earnings per share basis. Omnicell employs 2,480 workers across the globe.View Additional Information About Omnicell.

The official website for Omnicell is http://www.omnicell.com/.

Omnicell's mailing address is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The company can be reached via phone at 650-251-6100 or via email at [email protected]